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1607-551X/Copyright ª 2014, KaohsiuAbstract Although understanding the relation between psychotic behavior and immune ab-
normalities has been the focus of research for many years, it remains to be elucidated whether
the changes in cytokine levels are part of etiology or a result of the stress associated with the
disorder. In accordance with previous studies on changes in cytokine levels due to metabolic
changes and psychosis, we hypothesized that fatty liver may potentiate apomorphine-
induced stereotypy in a rodent model and that a synthetic glucagon-like peptide-1 analog ex-
enatide would ameliorate this effect. In this study, 18 male Sprague Dawley albino mature rats
were used. We induced hepatosteatosis in these rats by feeding them with 30% fructose dis-
solved in drinking water for 8 weeks. The animals were divided into three groups, namely,
the normal group, the intracerebroventricular (ICV) exenatide group, and the ICV NaCl group.
Apomorphine-induced stereotypic behavior test was performed in all groups and the liver was
removed for histopathological examination after all the rats were euthanized. In the nonalco-
holic fatty liver (NAFL) group, stereotypy scores were significantly increased compared with
the control group rats (p < 0.00001). A significant decrease in stereotypy scores were observed
in the ICV exenatide group with NAFL when compared with the ICV saline group with NAFL
(p < 0.005). In addition, brain malondialdehyde and tumor necrosis factor-a levels decreased
in the ICV exenatide group. The results of this study showed that fatty liver enhances theeclare no conflicts of interest.
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448 O. Erbas‚ et al.effect of apomorphine on stereotypy, which was reversed by exenatide possibly by antioxidant
and anti-inflammatory effects.
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Nonalcoholic fatty liver disease (NAFLD) is a condition in
which there is accumulation of fat in the liver in the
absence of significant alcohol consumption and other spe-
cific causes of hepatic steatosis. The clinical manifestation
ranges from asymptomatic steatosis to nonalcoholic stea-
tohepatitis (NASH) and cirrhosis [1,2]. Fatty liver is common
among patients with obesity and type 2 diabetes mellitus
(DM) [3]. Lipid peroxidation, oxidative stress, hyperglyce-
mia, hyperinsulinemia, and endotoxemia are the possible
pathophysiological events in NAFLD [4,5]. Cytokines also
have an important role in the development of NAFLD [6].
Among them, tumor necrosis factor-a (TNF-a) is an in-
flammatory cytokine secreted by different cell types
including macrophages and Kupffer cells in the liver and
plays a key role in the pathogenesis of inflammation and
insulin resistance. Several studies have suggested a rela-
tionship between TNF-a levels and obesity and insulin
resistance [7,8]. Interleukin-6 (IL-6) is another proin-
flammatory cytokine, which is induced by TNF-a, and its
serum levels were found to be higher in patients with
NAFLD and in animal models [9,10]. It is also considered to
have a close relation with liver diseases associated with
alcohol [2,11].
Many previous studies have analyzed the connection
between schizophrenia and immune abnormalities, and
schizophrenia has been found to be associated with altered
levels of cytokines and their soluble receptors such as IL-6,
sIL-6R, IL-8, IL-10, IL-4, TNF-a, and IL-1 beta levels [12,13].
Although apomorphine-induced stereotypic behavior test is
not a schizophrenia model, stereotypic behavior is
commonly used in many previous animal studies as the sign
of psychotic symptoms due to its common association with
schizophrenia [14e16]. Some studies have suggested a
close relationship between psychotic stereotypic behavior
and inflammation, and reported increased psychotic
behavior with the increasing levels of many cytokines
including TNF-a and IL-6 [17,18].
Glucagon-like peptide-1 (GLP-1) is an incretin hormone
that plays many important roles in the regulation of glucose
homeostasis. It is secreted from intestinal L cells in
response to carbohydrates [19]. GLP-1 is also produced in
the central nervous system by the neurons in nucleus
tractus solitarius (NTS). GLP-1 neurons in the NTS project to
regions including the ventral tegmental area and the nu-
cleus accumbens [20].
In this study, we aimed to investigate the relationship
between behavioral stereotypy, inflammatory response,
and oxidative stress by measuring brain TNF-a and malon-
dialdehyde (MDA) levels in hepatosteatosis-induced rats fed




In this study, 24 male Sprague Dawley albino mature rats
were used (aged: 8 weeks of age; weight: 250e300 g). The
experimental procedures of this study were approved by
the Ege University Animal Ethics Committee (Izmir, Turkey).
All experiments were carried out according to the Guide for
the Care and Use of Laboratory Animals, as confirmed by
the National Institutes of Health (Bethesda, MD, USA).
The rats were kept in a 12/12-hour lightedark cycle
(light from 7:00 AM to 19:00 AM) in quiet rooms with 22e24C
of ambient temperature. The animals were fed standard
laboratory food and tap water ad libitum.
Experimental protocol
We induced hepatosteatosis in 18 rats by feeding them with
30% fructose dissolved in drinking water for 8 weeks. The
remaining six male rats served as the control group and
received normal nutrition and drinking water.
The fructose-treated group was subdivided into three
groups. The first group (n Z 6) received ICV infusion of
exenatide (n Z 6). The second group received ICV infusion
of NaCl (n Z 6), and the third group just received the ICV
injection under anesthesia. Rats were deeply anesthetized
with an intraperitoneal (i.p.) injection of a mixture of ke-
tamine hydrochloride (40 mg/kg; Alfamine, Ege Vet, Alfa-
san International B.V., Woerden, The Netherlands) and
xylazine hydrochloric (4 mg/kg; Alfazyne, Ege Vet, Alfasan
International B.V.) and placed in a stereotaxic frame.
Exenatide 10 mg/kg (Byetta, Lilly) was infused into the left
lateral ventricle (anterioreposterior Z 0.8 mm;
medialelateralZ 1.6 mm; dorsaleventralZ 4.2 mm) at
a dose of 10 mL using a 28-gauge Hamilton syringe. Sham-
operated rats received 10 mL of isotonic NaCl (vehicle).
The needle was left in place for an additional 2 minutes for
complete diffusion of the drug. All animals received i.p.
injection of penicillin to prevent the postsurgical infection.
After the surgery, rats were weighed regularly and their
behavior and health conditions were monitored daily.
Apomorphine-induced stereotypic behavior test
Mesolimbic and nigrostriatal dopaminergic pathways play
crucial roles in the mediation of locomotor activity and
stereotypic behavior. Apomorphine-induced stereotypy is a
convenient method used in in vivo tests for evaluating the
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the assessment of dopaminergic activity [21,22].
Seven days after the stereotaxic surgery, apomorphine
(1.5 mg/kg subcutaneously) was administered to all ani-
mals. Stereotypic behavior was assessed by two indepen-
dent observers who were blinded to the study groups. All
studies were conducted between 10.00 AM and 16.00 PM.
First, rats were placed into cylindrical metal cages
(18 cm  19 cm) containing vertical (1 cm apart) and hor-
izontal (4.5 cm apart) metal bars (2 mm) with an upper lid
for 10 minutes (orientation period). After the administra-
tion of apomorphine, the rats were immediately placed
back into the metal cages and their stereotypic behavior
was observed. Signs of stereotypy, which include mainly
sniffing and gnawing, were observed and scored as follows:
absence of stereotypy (0), occasional sniffing (1), occa-
sional sniffing with occasional gnawing (2), frequent
gnawing (3), intense continuous gnawing (4), and intense
gnawing and staying on the same spot (5). The stereotypic
behavior was rated after each minute and the mean value
for a 15-minute period was calculated and recorded.
Measurement of brain lipid peroxidation (MDA)
Lipid peroxidation was determined in tissue samples by
measuring MDA levels as thiobarbituric acid-reactive sub-
stances (TBARSs) [23]. In brief, trichloroacetic acid and
TBARS reagent were added to the tissue samples, and the
samples were then mixed and incubated at 100C for 60
minutes. After cooling on ice, the samples were centrifuged
at 3000 rpm for 20 minutes and the absorbance of the su-
pernatant was read at 535 nm. MDA levels were calculated
from the standard calibration curve using tetraethox-
ypropane and were expressed as nmol/g protein.
Measurement of brain protein levels
Total protein concentration in brain samples was deter-
mined according to the Bradford method using bovine
serum albumin as standard [24].
Detection of TNF-a in brain tissue
The frozen brain tissues were homogenized with a glass ho-
mogenizer in 1 mL of buffer containing 1 mmol/L of phenyl-
methylsulfonyl fluoride, 1 mg/L of pepstatin A, 1 mg/L of
aprotinin, and 1 mg/L of leupeptin in phosphate-buffered
saline (PBS) solution (pH 7.2), and were then centrifuged at
12,000 rpm for 20 minutes at 4C. The supernatant was then
collected and the total protein was determined according to
the Bradford method. The level of TNF-a in the tissue su-
pernatants was measured using a commercially available rat
enzyme-linked immunosorbent assay kit (eBioscience, Inc,
San Diego, CA, USA) in accordance with the instructions of
the manufacturer. The interassay and intra-assay co-
efficients of variation for TNF-a were 7.9e8.2% and
6.1e6.5%, respectively. The minimum limit of TNF-a detec-
tedwas 4pg/mL. Thecytokine content in thebrain tissuewas
expressed as picogram of cytokines/gram of protein.Histopathological examination of liver
For histological and immunohistochemical studies, all ani-
mals were anesthetized by an i.p. injection of ketamine(40 mg/kg)/xylazine (4 mg/kg) and the liver was perfused
with 200 mL of 4% formaldehyde in 0.1M PBS. Formalin-
fixed liver sections (4 mm) were stained with hematox-
ylineeosin. All sections were photographed with Olympus
C-5050 digital camera mounted on Olympus BX51
microscope.
Morphological analysis was performed using a comput-
erized image analysis system (Image-Pro Express 1.4.5;
Media Cybernetics, Inc., USA) on 10 microscopic fields per
section examined at a magnification of 40 by the
observer blinded to the study groups. The pathologic
findings in the liver were scored by the percentage of liver
cells containing fat as follows [25]: (1) 1þ, <25% of cells
containing fat; (2) 2þ, 26e50% of cells containing fat; (3)
3þ, 51e75% of cells containing fat; and (4) 4þ, more than
75% of cells containing fat; (5) inflammation and necrosis:
one focus/lobule, 1þ; and (6) two or more foci/lobule,
2þ.
The total liver pathology score was calculated by adding
the scores from each parameter.Statistical analysis
Statistical evaluation was performed using SPSS version
15.0 for Windows (SPSS Inc., Chicago, IL, USA). Shapir-
oeWilk test was used to determine normal distribution of
data. Because all the data had a normal distribution, all
groups were compared using analysis of variance. By
contrast, post hoc Bonferroni test was used to compare the
two groups with each other. The results are presented as
mean  standard error of the mean and p < 0.05 was
accepted as being statistically significant.Results
Comparison of the stereotypy scores
Macrovesicular hepatosteatosis was shown histologically in
animals fed with fructose. In hepatosteatotic rats, ste-
reotypy scores were significantly increased compared with
the control group rats (F Z 14.59, p < 0.00001). Impor-
tantly, a significant decrease in stereotypy scores was
found in the fatty liver þ ICV exenatide group compared
with the fatty liver þ ICV saline group (p < 0.005; Table 1
and Figs. 1e3).Comparison of the brain TNF-a levels
The brain TNF-a levels were significantly increased in the
fatty liver and fatty liver þ NaCl groups when compared
with the control group (FZ 14.47, p < 0.00001). Brain TNF-
a levels were significantly decreased in rats treated with
exenatide when compared with the fatty liver and fatty
liver þ NaCl groups (FZ 16.56, p < 0.0005). When the fatty
liver þ NaCl and fatty liver groups were compared with
each other for brain TNF-a levels, there was no significant
difference (p > 0.05). In addition, there was no significant
difference in TNF-a levels between the fatty
liver þ exenatide and control groups (p > 0.05).
Table 1 Stereotypy and histopathologic liver scores of animals in the study groups.
Control NAFL NAFL þ ICV NaCl NAFL þ ICV exenatide
Stereotypy score (counts/min) 1.9  0.06 3.7  0.24* 4.2  0.23* 3.05  0.26**
Histopathologic liver score 1.08  0.15 5.09  0.32* 5.16  0.27 5.25  0.21
Data are expressed as mean  standard error of the mean. Statistical analyses were performed by analysis of variance and Student t
test.
*p < 0.000001 (in the NAFL and NAFL þ ICV NaCl groups, stereotypy histopathologic liver scores are higher for the control group).
**p < 0.005 (in the NAFL þ ICV exenatide group, stereotypy scores are lower for the NAFL þ ICV NaCl and NAFL groups).
ICV Z intracerebroventricular; NAFL Z nonalcoholic fatty liver.
Figure 1. Stereotypy scores (count/minute).
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The brain MDA levels were significantly increased in the
fatty liver and fatty liver þ NaCl groups when compared
with the control group (F Z 11.53, p < 0.005) and signifi-
cantly decreased in the exenatide-treated group when
compared with the fatty liver and fatty liver þ NaCl groups
(F Z 14.36, p < 0.0005). There was no significant differ-
ence in brain MDA levels between the fatty liver þ NaCl and
fatty liver groups (p > 0.05) and between the fatty
liver þ exenatide and control groups (p > 0.05; Table 2).Discussion
The results of this study showed that fatty liver enhances
the effect of apomorphine on stereotypy, which was
reversed by exenatide possibly by antioxidant and anti-
inflammatory effects. One of the most remarkable results
of this study is the change in the levels of brain MDA and
TNF-a. Both the brain MDA level, which is an important
indicator of oxidant status, and the brain TNF-a level,
which is a main road network of the inflammation, wereFigure 2. Histopathologic liver scores.significantly decreased in the group treated with exena-
tide. Thus, it can be suggested that exenatide may have
relevant effects on stereotypic behavior through its anti-
inflammatory and antioxidant features. Another significant
result of the study is that inflammatory and oxidant
markers in the fatty liver group increased significantly,
supporting the recently overemphasized relation between
inflammation and the stereotypic behavior.
Previously, Dixit et al. [19] showed antipsychotic-like
effect of the GLP-1 agonist liraglutide in a mouse model
of psychosis. In their study, acute liraglutide treatment
significantly attenuated apomorphine-induced cage climb-
ing, whereas sitagliptin, a dipeptidyl peptidase (DPP) in-
hibitor, failed to exhibit the same effect. The reason for
this failure was attributed to the moderate ability of sita-
gliptin to increase GLP-1 levels compared with direct GLP-1
activation by liraglutide and the absence of reports of DPP-
4 inhibitors, such as liraglutide and exenatide, crossing the
bloodebrain barrier (BBB) [19]. In our study, although
exenatide is known to be able to cross the BBB, it was
administered ICV and reduced the stereotypy scores
significantly in rats with fatty liver.
Mesolimbic and nigrostriatal dopaminergic pathways
have been suggested to play a crucial role in the mediation
of locomotor activity and stereotypic behavior. Apomor-
phine has been suggested to induce stereotypy by stimu-
lating the dopamine receptors. As mentioned earlier,
stereotypic behavior is suggested to be mediated by post-
synaptic dopamine receptors in the brain and this effect is
enhanced by apomorphine administration [21]. Likewise, in
our study, apomorphine-treated rats exhibited higher ste-
reotypy scores compared with controls without fatty liver.
This result might be due to the enhancing effect of fatty
liver on stereotypy by dopaminergic transmission. IL-2 has
been suggested to alter the dopaminergic activity in mes-
olimbic and striatal pathways. Accordingly, in 2013, Rankin
et al. [26] demonstrated that mice treated with GBR
1209da selective dopamine reuptake inhibitord30 days
after an initial IL-2 administration showed increased ste-
reotypical behavior, suggesting an IL-2 mechanism utilizing
dopamine. Likewise, in our study, apomorphine provoked
stereotypical behavior in mice with fatty liver possibly by
dopaminergic pathways.
The serum levels of cytokines such as IL-1 beta, IL-6, IL-
12, TNF-a, and sIL-2R were found to be high in several
studies, supporting the role of cytokines in the etiology of
psychosis [27e31]. IL-2 is specifically a T-helper Type 1-
derived cytokine that modulates the dopamine activity. It
has been suggested that stress factors such as infection and
inflammation during pregnancy may affect the mesolimbic
Figure 3. Liver histopathology. (A,B) Normal group liver (hematoxylineeosin; magnification, 40 and 100). (C,D) The hep-
atosteatosis group liver (arrow shows macrovesicular steatosis in liver cytoplasm).
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and hypersensitivity to drugs of abuse [32,33].
In NAFLD, chronic inflammation is considered to have a
pivotal role. TNF-a, IL-1 beta, IL-6, and IL-8 were found to
be elevated in NAFLD and in related diseases such as NASH,
alcoholic hepatitis, and DM in many previous studies
[2,6,11,34,35]. Thus, an inflammatory state, which is
possibly mediated through cytokines, may play a role in






Control group 14.08  1.2 118.2  6.49
NAFL 68.5  2.6* 475.8  7.24**
NAFL þ ICV NaCl 81.3  3.4* 502.7  4.18**
NAFL þ ICV exenatide 19.4  1.5*** 146.3  5.41****
Data are expressed as mean  standard error of the mean.
*p < 0.005 (in the NAFL and NAFL þ NaCl groups, brain MDA
levels are higher for the control group).
**p < 0.00001 (in the NAFL and NAFL þ NaCl groups, brain TNF-a
levels are higher for the control group).
***p < 0.00005 (in the NAFL þ ICV exenatide group, brain TNF-a
levels are lower for the NAFL and NAFL þ NaCl groups).
****p < 0.0005 (in the NAFL þ ICV exenatide group, brain MDA
levels are lower for the NAFL and NAFL þ NaCl groups).
ICV Z intracerebroventricular; MDA Z malondialdehyde;
NAFL Z nonalcoholic fatty liver; TNF-a Z tumor necrosis fac-
tor-a.NASH. In our study, animals with fatty liver exhibited
increased stereotypy, possibly related to the increased
levels of cytokines resulting from the development of
steatosis in liver. Increased stereotypy in our study was
reversed by exenatide da synthetic version of exendin-4.
Kim et al. [30] demonstrated a decrease in both basal lo-
comotor activity and amphetamine-induced locomotor ac-
tivity in rats treated with exendin-4. Furthermore,
Egecioglu et al. [36] demonstrated attenuated alcohol-
induced locomotor stimulation and accumbal dopamine
release in mice. The effects of GLP-1 analogs such as
attenuation of alcohol- and amphetamine-induced loco-
motor activity and accumbal dopamine release combined
with our results demonstrating a decrease in stereotypic
behavior with exenatide reveal the central effects of GLP-1
analogs.
In conclusion, the results of this study suggest that fatty
liver enhances the effects of apomorphines on stereotypy.
This effect might result from, at least in part, a possible
increase in cytokine levels due to an inflammatory state
induced by fatty liver. Importantly, this effect was reversed
by exenatide, suggesting a possible antipsychotic-like ef-
fect for peptide. Further studies in other animal psychosis
model are therefore needed to identify the modified
dopaminergic transmission effects of exenatide and to
define specific roles of inflammatory cytokines in psychosis.References
[1] Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC,
McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of
452 O. Erbas‚ et al.clinical and pathological severity. Gastroenterology 1999;116:
1413e9.
[2] Youssef W, McCullough AJ. Diabetes mellitus, obesity, and
hepatic steatosis. Semin Gastrointest Dis 2002;13:17e30.
[3] Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver
disease in type 2 diabetes and management of patients with
diabetes and liver disease. Diabetes Care 2007;30:734e43.
[4] Pappachan JM, Antonio FA, Edavalath M, Mukherjee A. Non-
alcoholic fatty liver disease: a diabetologist’s perspective.
Endocrine 2014;45:344e53.
[5] Oliver FWJ, Christoph PD. Non-alcoholic steatohepatitis
(NASH): a disease of emerging identity and importance. J
Hepatol 1998;29:495e501.
[6] Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of
cytokines and chemokines in non-alcoholic fatty liver disease.
World J Gastroenterol 2012;18:727e35.
[7] Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A,
Wadden T. Tumor necrosis factor-alpha in sera of obese pa-
tients: fall with weight loss. J Clin Endocrinol Metab 1998;83:
2907e10.
[8] Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM.
Increased adipose tissue expression of tumor necrosis factor-
alpha in human obesity and insulin resistance. J Clin Invest
1995;95:2409e15.
[9] Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al.
Local and systemic insulin resistance resulting from hepatic
activation of IKK-beta and NF-kappaB. Nat Med 2005;11:
183e90.
[10] Haukeland JW, Dama˚s JK, Konopski Z, Løberg EM, Haaland T,
Goverud I, et al. Systemic inflammation in nonalcoholic fatty
liver disease is characterized by elevated levels of CCL2. J
Hepatol 2006;44:1167e74.
[11] Tilg H, Diehl AM. Cytokines in alcoholic and non-alcoholic
steatohepatitis. N Engl J Med 2000;343:1467e76.
[12] Maes M, Bocchio Chiavetto L, Bignostti S, Battisa Tura GJ,
Pioli R, Boin F, et al. Increased serum interleukin-8 and
interleukin-10 in schizophrenic patients resistant to treatment
with neuroleptics and the stimulatory effects of clozapine on
serum leukemia inhibitory factor receptor. Schizophr Res
2002;54:281e91.
[13] Mu¨ller N, Empl M, Riedel M, Schwarz M, Ackenheil M. Neuro-
leptic treatment increases soluble IL-2 receptors and de-
creases soluble IL-6 receptors in schizophrenia. Eur Arch
Psychiatry Clin Neurosci 1997;247:308e13.
[14] Langlois X, Megens A, Lavreysen H, Atack J, Cik M, te Riele P,
et al. Pharmacology of JNJ-37822681, a specific and fast-
dissociating D2 antagonist for the treatment of schizo-
phrenia. J Pharmacol Exp Ther 2012;342:91e105.
[15] Sotoing Taı¨we G, Ngo Bum E, Talla E, Dawe A, Okomolo
Moto FC, Temkou Ngoupaye G. Antipsychotic and sedative
effects of the leaf extract of Crassocephalum bauchiense
(Hutch.). J Ethnopharmacol 2012;143:213e20.
[16] Erbas O, Taskıran D. Sepsis-induced changes in behavioral
stereotypy in rats; involvement of tumor necrosis factor-
alpha, oxidative stress, and dopamine turnover. J Surg Res
2014;186:262e8.
[17] Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM.
Interleukin-2 and -6 induce behavioral-activating effects in
mice. Brain Res 1998;811:111e21.
[18] Zalcman S. Interleukin-2-induced increases in climbing
behavior: inhibition by dopamine D-1 and D-2 receptor an-
tagonists. Brain Res 2002;944:157e64.
[19] Dixit TS, Sharma AN, Lucot JB, Elased KM. Antipsychotic-like
effect of GLP-1 agonist liraglutide but not DPP-IV inhibitorsitagliptin in mouse model for psychosis. Physiol Behav 2013;
10:114e5.
[20] Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A.
Exendin-4 decreases amphetamine-induced locomotor activ-
ity. Physiol Behav 2012;106:574e8.
[21] Dong SM, Kim YG, Heo J, Ji MK, Cho JW, Kwak BS. YKP1447, a
novel potential atypical antipsychotic agent. Korean J Physiol
Pharmacol 2009;13:71e8.
[22] Reavill C, Kettle A, Holland V, Riley G, Blackburn TP. Atten-
uation of haloperidol induced catalepsy by a 5-HT2C receptor
antagonist. Br J Pharmacol 1999;126:572e4.
[23] Demougeot C, Marie C, Beley A. Importance of iron location in
iron-induced hydroxyl radical production by brain slices. Life
Sci 2000;67:399e410.
[24] Bradford MM. A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle
of protein-dye binding. Anal Biochem 1976;72:248e54.
[25] French SW, Miyamoto K, Tsukamoto H. Ethanol-induced he-
patic fibrosis in the rat: role of the amount of dietary fat.
Alcohol Clin Exp Res 1986;10:13e9.
[26] Rankin JS, Zalcman SS, Zhu Y, Siegel A. Short and long term
sseffects of interleukin-2 treatment on the sensitivity of
periadolescent female mice to interleukin-2 and dopamine
uptake inhibitor. PLoS One 2013;24:64473.
[27] Crespo-Facorro B, Carrasco-Marin E, Perez-Iglesias R, Pelayo-
Teran JM, Fernandez-Prieto L, Leyva-Cobian F, et al. Inter-
leukin-12 plasma levels in drug-naive patients with a first
episode of psychosis: effects of antipsychotic drugs. Psychia-
try Res 2008;158:206e16.
[28] Fernandez-Egea E, Bernardo M, Donner T, Conget I,
Parellada E, Justicia A. Metabolic profile of antipsychotic-
naive individuals with non-affective psychosis. Br J Psychia-
try 2009;194:434e8.
[29] Anguli R, Rabin BS. Increased serum interleukin 2 receptor
concentration in schizophrenic and brain-damaged subjects.
Arch Gen Psychiatry 1989;46:292.
[30] Kim YK, Kim L, Lee MS. Relationships between interleukins,
neurotransmitters and psychopathology in drug-free male
schizophrenics. Schizophr Res 2000;44:165e75.
[31] Theodoropoulou S, Spanakos G, Baxevanis CN, Economou M,
Gritzapis AD, Papamichail MP. Cytokine serum levels, autolo-
gous mixed lymphocyte reaction and surface marker analysis
in never medicated and chronically medicated schizophrenic
patients. Schizophr Res 2001;47:13e25.
[32] Nawa H, Takei N. Recent progress in animal modeling of im-
mune inflammatory processes in schizophrenia: implication of
specific cytokines. Neurosci Res 2006;56:2e13.
[33] Watanabe Y, Someya T, Nawa H. Cytokine hypothesis of
schizophrenia pathogenesis: evidence from human studies and
animal models. Psychiatry Clin Neurosci 2010;64:217e30.
[34] Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ,
Grose RH, Cummins AG. The role of small intestinal bacterial
overgrowth, intestinal permeability, endotoxaemia, and
tumor necrosis factor alpha in the pathogenesis of non-
alcoholic steatohepatitis. Gut 2001;48:206e11.
[35] Yang SQ, Liu HZ, Lane MD, Clemens M, Diehl AM. Obesity in-
creases sensitivity to endotoxin liver injury: implications for
the pathogenesis of the steatohepatitis. Proc Natl Acad Sci
USA 1997;94:2557e62.
[36] Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA,
Jerlhag E. The glucagon-like peptide 1 analogue exendin-4
attenuates alcohol mediated behaviors in rodents. Psycho-
neuroendocrinology 2013;38:1259e70.
